NewEdge Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-227
Closed -$4.35K 4384
2026
Q1
$4.35K Buy
227
+127
+127% +$2.76K ﹤0.01% 3632
2025
Q4
$2.2K Hold
100
﹤0.01% 3868
2025
Q3
$1.21K Sell
100
-352
-78% -$4.76K ﹤0.01% 3856
2025
Q2
$8.43K Hold
452
﹤0.01% 3256
2025
Q1
$8.66K Buy
452
+294
+186% +$8.6K ﹤0.01% 3150
2024
Q4
$5.69K Hold
158
﹤0.01% 3196
2024
Q3
$6.7K Hold
158
﹤0.01% 3068
2024
Q2
$6.37K Hold
158
﹤0.01% 3012
2024
Q1
$5.59K Buy
+158
New +$4.23K ﹤0.01% 3100
2023
Q2
Sell
-22
Closed -$894 3628
2023
Q1
$894 Sell
22
-504
-96% -$20.9K ﹤0.01% 3170
2022
Q4
$22.7K Buy
+526
New +$23.8K ﹤0.01% 2082
2020
Q2
Sell
-11,483
Closed -$739K 939
2020
Q1
$739K Sell
11,483
-6,576
-36% -$461K 0.04% 371
2019
Q4
$1.08M Sell
18,059
-657
-4% -$40.5K 0.04% 339
2019
Q3
$1.18M Buy
+18,716
New +$1.19M 0.05% 317
2019
Q2
Sell
-15,871
Closed -$1.01M 702
2019
Q1
$1.01M Buy
15,871
+9,479
+148% +$498K 0.07% 275
2018
Q4
$243K Buy
+6,392
New +$226K 0.02% 544

Other funds holding TNDM

NewEdge Advisors's TNDM Position: Q2 2026 in Review

NewEdge Advisors sold out of Tandem Diabetes Care (TNDM) in Q2 2026, closing a stake of 227 shares — an estimated $4.35K sold.

NewEdge Advisors first reported a position in TNDM in Q4 2018 and held it in 16 quarters. The position peaked at $1.18M in Q3 2019. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • NewEdge Advisors reported no remaining Tandem Diabetes Care position as of Q2 2026 after selling out during the quarter.
  • NewEdge Advisors sold 227 Tandem Diabetes Care shares in Q2 2026, an estimated $4.35K.
  • NewEdge Advisors first reported a position in Tandem Diabetes Care in Q4 2018 and held it in 16 quarters.
  • NewEdge Advisors's Tandem Diabetes Care position peaked at $1.18M in Q3 2019.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.